Puma Biotechnology Inc
NASDAQ:PBYI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Puma Biotechnology Inc
NASDAQ:PBYI
|
US |
|
IDG Energy Investment Ltd
HKEX:650
|
HK |
|
Hon Hai Precision Industry Co Ltd
TWSE:2317
|
TW |
|
Veste SA Estilo
BOVESPA:VSTE3
|
BR |
|
Aguia Resources Ltd
ASX:AGR
|
AU |
|
TCS Group Holding PLC
LSE:TCS
|
CY |
Wall Street
Price Targets
PBYI Price Targets Summary
Puma Biotechnology Inc
According to Wall Street analysts, the average 1-year price target for
PBYI
is 5.1 USD
with a low forecast of 5.05 USD and a high forecast of 5.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PBYI's stock price target?
Price Target
5.1
USD
According to Wall Street analysts, the average 1-year price target for
PBYI
is 5.1 USD
with a low forecast of 5.05 USD and a high forecast of 5.25 USD.
What is Puma Biotechnology Inc's Revenue forecast?
Projected CAGR
-1%
The
compound annual growth rate
of Puma Biotechnology Inc's revenue for the next 3 years is
-1%.
What is Puma Biotechnology Inc's Operating Income forecast?
Projected CAGR
-12%
The
compound annual growth rate
of Puma Biotechnology Inc's operating income for the next 3 years is
-12%.
What is Puma Biotechnology Inc's Net Income forecast?
Projected CAGR
-9%
The
compound annual growth rate
of Puma Biotechnology Inc's net income for the next 3 years is
-9%.
